Companies: 10,795·Total market cap: $144.5T
DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Inc.

DMACNASDAQHealthcare● Active
$5.52
$-0.12(-2.13%)
Market Cap$297435816
P/E Ratio—
52W High$10.4195
52W Low$3.475
SEC Filings

DiaMedica Therapeutics Inc. (DMAC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001401040 · DMAC · NASDAQ · as of Jun 8, 2026

Filing snapshot

423
Total Filings
4
Latest Form
2026-06-03
Most Recent
2012
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001401040 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-30
Fiscal Year End
Mar 30, 2026
Accession No.
0001437749-26-010342
Primary Document
dmtp20251231_10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001401040 · Accession 0001437749-26-010342

Latest Key Filings

10-QQuarterly Report
FORM 10-Q
2026-05-06
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2026-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
8-KCurrent Report
FORM 8-K
2026-05-21
View
10-QQuarterly Report
FORM 10-Q
2026-05-06
View
8-KCurrent Report
FORM 8-K
2026-05-06
View
ARSARS
ARS
2026-04-01
View
DEFA14AProxy Statement (Additional)
FORM DEFA14A
2026-04-01
View
DEF 14AProxy Statement
FORM DEF 14A
2026-04-01
View
8-KCurrent Report
FORM 8-K
2026-03-31
View
10-KAnnual Report
FORM 10-K
2026-03-30
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-06
View
8-KCurrent Report
FORM 8-K
2026-01-05
View
8-KCurrent Report
FORM 8-K
2025-12-18
View
S-8Employee Stock Plan Registration
FORM S-8
2025-11-13
View
10-QQuarterly Report
FORM 10-Q
2025-11-12
View
Showing 1–15 of 270 filingsForm 4 / 144 hidden· 423 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001401040  |  Exchange: NASDAQ · Healthcare

DiaMedica Therapeutics Inc. (NASDAQ: DMAC) has submitted 423 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2012. As a Healthcare sector company with CIK 0001401040, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is DiaMedica Therapeutics Inc.'s most comprehensive regulatory disclosure. The most recent DiaMedica Therapeutics Inc. 10-K was filed on 2026-03-30 for fiscal year ending 2026. Historical DMAC 10-K annual reports are available from 2007 through 2026.

Investors researching DiaMedica Therapeutics Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
DRTS SEC Filings →DSGN SEC Filings →ANNX SEC Filings →DBVT SEC Filings →ALT SEC Filings →IMAB SEC Filings →GALT SEC Filings →GNLX SEC Filings →
→ DMAC Financials→ DMAC Earnings→ DMAC Insider Trades

Frequently Asked Questions

DMAC SEC Filings · 8 questions

DiaMedica Therapeutics Inc. (DMAC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 423 filings and access original documents at no cost. DiaMedica Therapeutics Inc.'s CIK is 0001401040.

DMAC SEC filingsDiaMedica Therapeutics Inc. SEC documentsfind DMAC 10-K